Skip to main content
. Author manuscript; available in PMC: 2010 Feb 11.
Published in final edited form as: Vaccine. 2008 Dec 16;27(7):1050–1054. doi: 10.1016/j.vaccine.2008.11.100

Figure 1. The proportions of participants reporting occurrence of any (one or more) adverse reactions by vaccine or placebo group, and cohort (both year versus single year participants).

Figure 1

LAIV (live-attenuated influenza vaccine); placebo nasal (saline in year 1 and normal allantoic fluid in year 2); TIV (inactivated vaccine); placebo injected (saline both years)